Arunjyoti Bio Ventures Ltd Stock Price Today (NSE: ABVL)

Arunjyoti Bio Ventures Ltd

4.500.03 (0.66%)
Market Closed

Fundamental Score

...

Arunjyoti Bio Ventures Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Arunjyoti Bio Ventures Ltd share price today is 4.50, down 0.66% on NSE/BSE as of 17 September 2026. Arunjyoti Bio Ventures Ltd (ABVL) is a Small-cap company in the Other Financial Services sector with a market capitalisation of 83.87 (Cr). The 52-week high for ABVL share price is 12.71 and the 52-week low is 4.00. The company has a Return on Equity (ROE) of -14.65% and a debt-to-equity ratio of N/A.

Arunjyoti Bio Ventures Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
5.54
Low
4.50
Volume
1.7L
Change
-8.20%

Arunjyoti Bio Ventures Ltd share price chart: -8.20% return over the past month. 52-week high ₹12.71, 52-week low ₹4.00.

Arunjyoti Bio Ventures Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
4.504.574.484.502.02L (Cr)
4.554.644.514.5394.46K (Cr)
4.604.654.434.5878.45K (Cr)
4.554.744.504.551.25L (Cr)
4.805.104.004.622.83L (Cr)
4.734.994.614.842.41L (Cr)
4.664.744.664.7078.12K (Cr)
4.724.804.514.681.73L (Cr)
4.784.784.744.7662.85K (Cr)
4.754.844.704.731.06L (Cr)

Arunjyoti Bio Ventures Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
4.755.104.004.50-5.26%
5.185.544.804.90-5.41%
5.406.254.985.18-4.07%
5.606.255.025.48-2.14%
6.567.175.455.59-14.79%
6.5910.996.206.90+4.70%
8.008.385.676.43-19.63%
7.298.246.567.96+9.19%
8.408.406.387.07-15.83%
7.569.167.198.45+11.77%
11.4912.447.957.95-30.81%
9.6112.718.6811.72+21.96%

Returns & Performance

Poor

Return on Equity (ROE)

-14.65%

Profit generated per ₹1 of shareholder equity

Poor

Return on Assets (ROA)

-7.86%

Bank profit generated relative to total assets

Poor

Net Profit Margin

-6.53%

Net profit as a percentage of reported revenue/income

Dividend Yield

0.00%

Annual dividend as % of current share price

Arunjyoti Bio Ventures Ltd Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Average

Price to Book (P/B)

2.92x

Share price ÷ book value per share — key bank valuation metric

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

47.64%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-70.18%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

-5.88%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

38.17%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Banking balance-sheet metrics

Debt/Equity, interest coverage and industrial free-cash-flow ratios are not shown for banks because deposits and borrowings are part of the core lending business. Bull Run uses ROA, ROE, P/B and net profit margin above for bank analysis.

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Arunjyoti Bio Ventures Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ABVL across key market metrics for learning purposes.

Positive Indicators

2 factors identified

Consistent Growth Track Record (38.17% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Below-Average Return on Equity (-14.65%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Profit Decline Concern (-70.18%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Revenue Contraction (-5.88%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Arunjyoti Bio Ventures Ltd vs Other Financial Services Peers

Peer Comparison - Other Financial Services

Compare Arunjyoti Bio Ventures Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
17.6/100
5
₹83.87
-14.65%
Poor
38.17%
Excellent
0.00%
66.4/100
4691
₹34288.29
38.8
Average
27.37%
Excellent
14.40%
Good
12.99%
Good
0.59%
8/100
15
₹12118.00
-61.01%
Poor
0.00%
20.9/100
51
₹3896.81
114.9
Average
-1.81%
Poor
1.39%
Poor
0.2
Excellent
-32.89%
Poor
0.00%
45/100
132
₹2700.96
553.8
Average
17.57%
Good
198.76%
Excellent
356.32%
Excellent
0.01%
57.7/100
64
₹1793.11
45.6
Average
27.69%
Excellent
67.14%
Excellent
111.83%
Excellent
0.00%
53.9/100
189
₹1251.64
57.4
Average
5.24%
Poor
6.77%
Poor
0.0
Excellent
-18.20%
Poor
31.70%
Excellent
0.00%
0/100
22
₹1090.50
-46.79%
Poor
49.72%
Excellent
0.00%
35.4/100
280
₹950.66
169.8
Average
6.69%
Poor
2.90%
Average
25.66%
Excellent
0.54%
85/100
848
₹903.92
27.4
Average
27.72%
Excellent
24.61%
Excellent
23.58%
Excellent
2.10%
63.7/100
324
₹614.86
21.2
Average
20.57%
Excellent
27.26%
Excellent
0.2
Excellent
31.11%
Excellent
48.53%
Excellent
0.00%

Arunjyoti Bio Ventures Ltd PE Ratio History

Historical price-to-earnings ratio for ABVL — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20230.01₹22.152158x
FY 20220.00₹8.531722.6x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Arunjyoti Bio Ventures Ltd Quarterly Performance

Latest quarterly metrics for ABVL — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

-5.88%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-70.18%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

38.17%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Arunjyoti Bio Ventures Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ABVL — calculated from daily price history

25RSI 14
Oversold — RSI 25

Selling pressure is heavy — potential reversal zone.

SMA 50
5
▼ Price below SMA 50 — Short-term bearish
SMA 200
7
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
157K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Arunjyoti Bio Ventures Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Arunjyoti Bio Ventures Ltd (ABVL) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Arunjyoti Bio Ventures Ltd

Loading latest quarterly results...

About ABVL (Arunjyoti Bio Ventures Ltd)

Arunjyoti Bio Ventures Ltd is a dynamic entity operating within the Other Financial Services sector, leveraging its unique position to foster growth and innovation. While its roots... are firmly planted in traditional financial instruments, the company is steadily expanding its portfolio to include investments in sustainable and ecologically responsible ventures. Based in Hyderabad, India, ABVL is committed to identifying and nurturing emerging businesses that demonstrate a commitment to both profitability and environmental stewardship. With a focus on strategic partnerships and long-term value creation, Arunjyoti Bio Ventures aims to be a catalyst for positive change, driving financial returns while contributing to a more sustainable future. Their approach is marked by careful due diligence and a commitment to supporting ventures throughout their lifecycle. ABVL differentiates itself through a keen understanding of the evolving financial landscape, particularly the growing importance of Environmental, Social, and Governance (ESG) factors. The company's investment philosophy centers on identifying opportunities that align with global sustainability goals, recognizing that responsible investing is not only ethically sound but also economically advantageous in the long run. They employ a team of experienced professionals with expertise in financial analysis, venture capital, and sustainable business practices. This combination of skills allows them to thoroughly assess the potential of various ventures, providing not only capital but also strategic guidance and operational support. ABVL's commitment extends beyond mere financial investment, emphasizing a collaborative approach to foster lasting success. Originally established in 1986 as Century 21st Portfolio Limited, Arunjyoti Bio Ventures underwent a strategic transformation in 2014, signaling a renewed focus on bio-related and sustainable ventures. This evolution reflects the company's proactive approach to adapting to changing market dynamics and embracing emerging opportunities. With a strong foundation built on years of financial experience, ABVL is well-positioned to navigate the complexities of the modern investment landscape. The company's commitment to innovation and its emphasis on long-term value creation make it a compelling partner for businesses seeking both financial support and strategic guidance. By bridging the gap between financial expertise and sustainable business practices, Arunjyoti Bio Ventures aims to shape a more prosperous and environmentally responsible future.

Company Details

Symbol:ABVL
Industry:Other Financial Services
Sector:Other Financial Services

Key Leadership

Mr. Nadimpalli Vishal
CFO & Whole Time Director
Ms. Swati Jain
Company Secretary & Compliance Officer
Mr. Pabbathi Badari Narayana Murthy
Whole-time Director

ABVL Share Price: Frequently Asked Questions

What is the current share price of Arunjyoti Bio Ventures Ltd?

Arunjyoti Bio Ventures Ltd (ABVL) trades at ₹4.50 on NSE and BSE. Market cap ₹83.87 (Cr). Educational data only.

What is the P/E ratio of Arunjyoti Bio Ventures Ltd?

Arunjyoti Bio Ventures Ltd has a P/E of N/Ax vs industry average 27.57x.

What is the Bull Run score for Arunjyoti Bio Ventures Ltd?

Arunjyoti Bio Ventures Ltd has a Bull Run score of 17.6/100 based on 25+ financial parameters.

Does Arunjyoti Bio Ventures Ltd pay dividends?

Arunjyoti Bio Ventures Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Arunjyoti Bio Ventures Ltd?

Arunjyoti Bio Ventures Ltd has ROE of -14.65%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Arunjyoti Bio Ventures Ltd?

Arunjyoti Bio Ventures Ltd has debt-to-equity of N/A.

Is Arunjyoti Bio Ventures Ltd a good investment?

Bull Run gives Arunjyoti Bio Ventures Ltd a score of 17.6/100. This is not investment advice — consult a SEBI-registered advisor.